Cel-Sci
CVM
$1.63
Share price
10.14%
Change (1 day)
-31.51%
Change (1 year)
Categories
Operating Margin for Cel-Sci (CVM)
Operating Margin as of May 2024 (TTM): -5,975.84%
According to Cel-Sci 's latest financial reports and stock price the company's current Operating Margin is -5,975.84%. At the end of 2012 the company had an Operating Margin of -6,078.83%.
Operating Margin history for Cel-Sci from 2001 to 2012
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2012 | -6,078.83% | 223.16% |
| 2011 | -1,881.04% | -84.46% |
| 2010 | -12,107.14% | -19.33% |
| 2009 | -15,008.12% | -92.01% |
| 2008 | -187,804.40% | 1045.5% |
| 2007 | -16,395.02% | 284.52% |
| 2006 | -4,263.77% | 182.03% |
| 2005 | -1,511.82% | 19.3% |
| 2004 | -1,267.27% | -1.21% |
| 2003 | -1,282.84% | -21.56% |
| 2002 | -1,635.54% | -44.2% |
| 2001 | -2,931.14% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -100.38% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | -100.58% | 🇺🇸 USA |
 Xencor XNCR | -141.63% | -97.63% | 🇺🇸 USA |
 Curis CRIS | -426.66% | -92.86% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -99.66% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | -77.02% | -98.71% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 17.53% | -100.29% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.